Hon CHRIS HIPKINS: Well, that is of course another one of the reasons why our vaccine roll-out was slower to start than some other countries. We made the decision not to use an emergency approval process but to make sure it was run through a regular, thorough approval process. When we made that decision, it is worth remembering that we were seeing research that suggested up to a third of New Zealanders were not willing to have the vaccine at that time. By taking a thorough and considered approach to the roll-out of the vaccine, we have reduced that number down to a much, much smaller number.